All Stories

  1. Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST)
  2. The development of a financial toxicity patient-reported outcome in cancer: The COST measure
  3. A Value Framework in Head and Neck Cancer Care
  4. Financial distress in cancer patients
  5. A Checklist for Ascertaining Study Cohorts in Oncology Health Services Research Using Secondary Data: Report of the ISPOR Oncology Good Outcomes Research Practices Working Group
  6. Access to cancer medications in low- and middle-income countries
  7. Pharmacoeconomic issues in head and neck oncology
  8. Unsupported off-label chemotherapy in metastatic colon cancer
  9. Unsupported off-label use of cancer therapies: new challenges in the era of biopharmaceuticals
  10. Role of molecular markers in the management of head and neck cancers
  11. CYP2D6 Genotyping and Tamoxifen: An Unfinished Story in the Quest for Personalized Medicine
  12. Value-based insurance design in oncology
  13. The Global Breast Cancer Disparity
  14. Personalizing cancer care: updates on head and neck cancer
  15. Pilot Study of Targeted Skeletal Radiation Therapy for Bone-Only Metastatic Breast Cancer
  16. The Reply
  17. Molluscum or a Mimic?